Search

everythinglearnresearchcommunity

for

Search:↓

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Melamax® protects skin from UV damage and reduces inflammation and oxidative stress.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

New compounds may help treat heart disease by activating specific potassium channels.

Polygoni mulitiflori Radix water extracts promote hair growth and are safer than minoxidil.

High DKK1 levels predict worse survival in head and neck cancer.

Pumpkin seed products may help improve prostate and bladder health by blocking certain enzymes and hormone receptors.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Cilostazol helps hair grow by making hair root cells grow faster and changing growth factor levels.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Scopolin and scopoletin from Merremia peltata leaves may help treat hair loss and showed promising results in rabbit tests.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

Dutasteride and finasteride affect different cell types differently.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Computational methods help design drugs targeting prostate cancer proteins.

Finasteride increases CD8+ T cells in BPH tissues.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Micelles can change cetirizine's ionization, affecting its effectiveness in treatments.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Some minoxidil combinations can help differentiate leukemia cells without harming other cells.

The document concludes that DNA methylation and the mTOR pathway are important for stem cell function and could impact disease treatment.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.